Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | THPO | P40225 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | PSMB11 | A5LHX3 | 1/20 | 0.45 |
| ▸ | PSMA7 | O14818 | 1/20 | 0.45 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.45 |
| ▸ | PSMA1 | P25786 | 1/20 | 0.45 |
| ▸ | PSMA2 | P25787 | 1/20 | 0.45 |
| ▸ | PSMA3 | P25788 | 1/20 | 0.45 |
| ▸ | PSMA4 | P25789 | 1/20 | 0.45 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.45 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12308077 | 0.87 | ALDH1A1 (0.53) | ALDH1A1MAPTKDM4ETHRBALOX15 | |
| SCHEMBL10363717 | 0.86 | ALDH1A1 (0.52) | ALDH1A1MAPTKDM4ETHRBALOX15 | |
| SCHEMBL10363716 | 0.86 | ALDH1A1 (0.52) | ALDH1A1MAPTKDM4ETHRBALOX15 | |
| SCHEMBL11702076 | 0.84 | ALDH1A1 (0.50) | ALDH1A1MAPTKDM4ETHRBALOX15 | |
| SCHEMBL11555294 | 0.84 | ALDH1A1 (0.50) | ALDH1A1MAPTKDM4ETHRBALOX15 | |
| SCHEMBL30522059 | 0.83 | MAPT (0.46) | ALDH1A1MAPTKDM4ETHRBALOX15 | |
| SCHEMBL2428805 | 0.81 | ALDH1A1 (0.47) | ALDH1A1MAPTKDM4ETHRBALOX15 | |
| Dacisteine SCHEMBL2402188 | 0.81 | MAPT (0.55) | ALDH1A1MAPTKDM4ETHRBALOX15 | |
| Dacisteine SCHEMBL1814125 | 0.81 | MAPT (0.55) | ALDH1A1MAPTKDM4ETHRBALOX15 | |
| SCHEMBL9522833 | 0.81 | MAPT (0.47) | ALDH1A1MAPTKDM4ETHRBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995034303-A1 | METHOD FOR THE TREATMENT, PREVENTION OR MINIMIZATION OF HAIR LOSS | ARCTURUS PHARMACEUTICAL CORPORATION (US) | 1995-12-21 | — | — | WO | claimed |
| WO-1995017900-A1 | METHODS FOR THE TREATMENT OF THE CENTRAL NERVOUS SYSTEM OR EYE INVOLVING PATHOGENIC OXIDATION PATHWAYS | ARCTURUS PHARMACEUTICAL CORPORATION (US) | 1995-07-06 | — | — | WO | claimed |
| WO-1995000136-A1 | METHOD FOR TREATING HYPERKERATOSIS AND DISEASES MEDIATED BY PROTEASES | ARCTURUS PHARMACEUTICAL CORPORATION (US) | 1995-01-05 | — | — | WO | claimed |
| WO-1995026719-A1 | METHOD FOR DELIVERING BIOLOGICALLY ACTIVE MATERIALS USING A THIOESTER OR THIOETHER PRODRUG | ARCTURUS PHARMACEUTICAL CORPORATION (US) | 1995-10-12 | — | — | WO | disclosed |
| WO-1995017900-A1 | METHODS FOR THE TREATMENT OF THE CENTRAL NERVOUS SYSTEM OR EYE INVOLVING PATHOGENIC OXIDATION PATHWAYS | ARCTURUS PHARMACEUTICAL CORPORATION (US) | 1995-07-06 | — | — | WO | disclosed |
| WO-1995000136-A1 | METHOD FOR TREATING HYPERKERATOSIS AND DISEASES MEDIATED BY PROTEASES | ARCTURUS PHARMACEUTICAL CORPORATION (US) | 1995-01-05 | — | — | WO | disclosed |